Description

5-[(4-Methyl-1H-Pyrazol-1-Yl)Methyl]-2-Furoic Acid is a high-value, heterocyclic carboxylic acid derivative that serves as a critical building block in advanced organic synthesis. Its unique molecular architecture, combining a furoic acid moiety with a substituted pyrazole ring, makes it an essential intermediate for the development of novel active pharmaceutical ingredients (APIs) and agrochemicals. This compound is primarily sought by research institutions and industrial manufacturers in the pharmaceutical, agrochemical, and specialty chemical sectors for creating compounds with targeted biological activity.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in medicinal chemistry programs targeting inflammation, oncology, and metabolic diseases.
• Agrochemical Research: Used as a core scaffold for developing new-generation herbicides, fungicides, and insecticides with improved efficacy and environmental profiles.
• Ligand Synthesis: Employed in the preparation of specialized ligands for catalysis and metal-organic frameworks (MOFs) due to its chelating potential.
• Material Science: Acts as a monomer or functionalizing agent for creating polymers with specific thermal or optical properties.
• Chemical Biology Probes: Utilized in the design and synthesis of molecular probes for studying enzyme function and biological pathways.

Basic Information

Product Name	5-[(4-Methyl-1H-Pyrazol-1-Yl)Methyl]-2-Furoic Acid
CAS No.	957509-85-2
Molecular Formula	C10H10N2O3
Molecular Weight	206.20 g/mol
Synonyms	2-Furoic acid, 5-[(4-methyl-1H-pyrazol-1-yl)methyl]-; 5-((4-Methyl-1H-pyrazol-1-yl)methyl)furan-2-carboxylic acid; 5-[(4-Methylpyrazol-1-yl)methyl]-2-furoic acid; 1-(2-Carboxyfuran-5-ylmethyl)-4-methylpyrazole; 4-Methyl-1-(2-furoylmethyl)pyrazole; 5-[(4-Methyl-1H-pyrazol-1-yl)methyl]-2-furancarboxylic acid
EINECS	Contact for details

Quality Control

Our production of 5-[(4-Methyl-1H-Pyrazol-1-Yl)Methyl]-2-Furoic Acid adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Every lot is subjected to comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting all critical quality attributes. We operate under a cGMP-compliant quality system suitable for supporting pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is light-sensitive and should be stored away from direct light exposure. Keep the container tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.